Hello and Welcome to Patientsville.com, Your Source for all CALAN information. We are dedicated to provide You with CALAN safety information. Learn about CALAN serious adverse events reported to Food and Drug Administration (FDA).
CALAN Safety Reports
Total CALAN reports: 3. CALAN FDA safety alerts: No. . Read More Here.Physician from UNITED STATES reported CALAN problem on Mar 10, 2006. Female patient, 75 years of age, weighting 207.0 lb, was diagnosed with hypertension and was treated with CALAN. After drug was administered, patient experienced the following problems/side effects: headache, nausea, rash. CALAN dosage: unknown. During the same period patient was treated with AVAPRO. Patient recovered.
CALAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2006. Male patient, 41 years of age, weighting 215.0 lb, was diagnosed with heart rate irregular and was treated with CALAN. After drug was administered, patient experienced the following problems/side effects: crohn's disease, depression, nephrolithiasis. CALAN dosage: 240 MG. During the same period patient was treated with NEURONTIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CALAN problem on Feb 27, 2006. Male patient, 54 years of age, weighting 280.0 lb, was diagnosed with hypertension and was treated with CALAN. After drug was administered, patient experienced the following problems/side effects: intervertebral disc protrusion, narcolepsy, neck injury, road traffic accident, rotator cuff syndrome, sleep apnoea syndrome. CALAN dosage: 480 MG (240 MG, 2 IN 1 D). During the same period patient was treated with CARDURA, HYDROCHLOROTHIAZIDE, ZOLOFT, ALTACE, PROVIGIL, RITALIN, DRAVOCET, ETODOLAC. Patient recovered.